𝗡𝗘𝗪𝗦 → FDA releases final rule on Laboratory-Developed Tests (LDTs) 🚨

RQM+'s Bethany Knorr Chung, PhD, RAC and Margot Borgel, Ph.D. dive into the details of what you need to know, including:

✅ The 4-year phase-in timeline for compliance

✅ Expanded enforcement discretion for certain LDTs

✅ Grandfathering clause for currently marketed LDTs

Watch now to learn how this rule impacts your business and what steps you need to take to ensure compliance.

-

📹 ⁠⁠⁠⁠⁠⁠⁠⁠⁠View and share this clip on LinkedIn.⁠⁠⁠⁠⁠⁠⁠⁠⁠

📲 ⁠⁠⁠⁠⁠⁠⁠⁠⁠Follow RQM+ on LinkedIn.⁠⁠⁠⁠⁠⁠⁠⁠⁠

📚 ⁠⁠⁠⁠⁠⁠⁠⁠⁠See on-demand content in our Knowledge Center.⁠⁠⁠⁠⁠⁠⁠⁠⁠

📝 If you'd like to speak with us directly about how we might be able to support you and your organization, you're welcome to use ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠our contact form⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.